Nabarun Dasgupta

Nabarun Dasgupta is a quantitative epidemiologist who studies the medical and nonmedical use of prescription opioids and heroin. He has worked with and consults for diverse groups in public health involved in reducing the adverse consequences of opioid use, including clinical practices, non-profit organizations, state and local health departments, the World Health Organization, and the pharmaceutical industry. Nabarun is also involved in designing and evaluating interventions for reducing the unintended consequences of prescription opioid use. He is the co-founder of Project Lazarus (www.projectlazarus.org), a community-based pain management and overdose prevention non-profit organization in Appalachian North Carolina.

Beyond opioids, he works with CDC and FDA to create biosurveillance tools for bioterrorism, infectious disease reporting and prescription drug- and device-related adverse event monitoring, including mobile apps. He has helped develop post-marketing surveillance systems for pharmaceutical substances, through collaborations with government, industry and academic groups. His recent work has included developing prototype surveillance tools for situational awareness for drug safety and infectious diseases, including using news media, public electronic data sources, social media and hospital data. Nabarun is particularly interested in how information from informal sources can be used in conjunction with traditional public health surveillance to create a more robust picture of a epidemics and drug safety concerns.